Cronos Group Inc. (NASDAQ:CRON) reported a 21% increase in net revenue for the second quarter of 2025, reaching $33.5 million. The growth was attributed to strong cannabis flower sales in Israel and international markets, Cronos GrowCo consolidation, and improved Canadian extract sales. Gross profit rose to $14.5 million.

PEACE NATURALS®, a brand of Cronos Group Inc. (NASDAQ:CRON), maintained its position as the top cannabis brand in Israel. CEO Mike Gorenstein highlighted the company’s plans for flower capacity growth and global momentum to address supply limitations in Canada. The firm holds $834 million in cash with no debt.

While Cronos Group (NASDAQ:CRON) shows promise as an investment, some believe there are better opportunities in AI stocks with greater potential and lower risks. Investors looking for undervalued AI stocks can explore the best short-term AI stock for significant benefits from current economic trends.

Read more at Yahoo Finance: Cronos Group Releases 2025 Second Quarter Results